Exact Sciences (EXAS) News Today $45.84 -1.25 (-2.65%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by Zevenbergen Capital Investments LLCZevenbergen Capital Investments LLC cut its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 4.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,376,057 shares of the medical research company's stMarch 25 at 7:32 AM | marketbeat.comThrivent Financial for Lutherans Takes Position in Exact Sciences Co. (NASDAQ:EXAS)Thrivent Financial for Lutherans purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 120,555 shares of the medical research company'March 24 at 4:06 AM | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twenty brokerages that are presently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and eighteen have issueMarch 24 at 2:07 AM | marketbeat.com171,053 Shares in Exact Sciences Co. (NASDAQ:EXAS) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 171,053 shares of the medical reseMarch 22 at 3:17 AM | marketbeat.comExact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound?March 21, 2025 | msn.comPrimecap Management Co. CA Decreases Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Primecap Management Co. CA cut its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 479,300 shares of the medical research company's stocMarch 21, 2025 | marketbeat.comShould You Invest in Exact Sciences Corp. (EXAS)?March 20, 2025 | msn.comProficio Capital Partners LLC Purchases Shares of 28,545 Exact Sciences Co. (NASDAQ:EXAS)Proficio Capital Partners LLC acquired a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 28,545 shares of the medical research company's stock,March 20, 2025 | marketbeat.comNikko Asset Management Americas Inc. Sells 137,288 Shares of Exact Sciences Co. (NASDAQ:EXAS)Nikko Asset Management Americas Inc. lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 20.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 541,180 shares of the medical research company'March 18, 2025 | marketbeat.comWilliam Blair Investment Management LLC Lowers Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)William Blair Investment Management LLC lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 19.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,444,511 shares of theMarch 18, 2025 | marketbeat.comSwiss National Bank Sells 25,800 Shares of Exact Sciences Co. (NASDAQ:EXAS)Swiss National Bank reduced its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 4.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 521,880 shares of the medical research company's stock afterMarch 18, 2025 | marketbeat.com10,578 Shares in Exact Sciences Co. (NASDAQ:EXAS) Bought by Parnassus Investments LLCParnassus Investments LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 10,578 shares of the medical research company's stock, valued at approMarch 16, 2025 | marketbeat.comTredje AP fonden Has $791,000 Position in Exact Sciences Co. (NASDAQ:EXAS)Tredje AP fonden trimmed its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 50.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,080 shares of the medical research company's stock after selling 1March 16, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Now Covered by Analysts at Royal Bank of CanadaMarch 16, 2025 | americanbankingnews.comPostrock Partners LLC Purchases New Stake in Exact Sciences Co. (NASDAQ:EXAS)Postrock Partners LLC acquired a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 12,309 shares of the medical research company's stock, vMarch 15, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Down 6.4% - What's Next?Exact Sciences (NASDAQ:EXAS) Trading Down 6.4% - Here's What HappenedMarch 14, 2025 | marketbeat.comRoyal Bank of Canada Begins Coverage on Exact Sciences (NASDAQ:EXAS)Royal Bank of Canada assumed coverage on Exact Sciences in a research report on Thursday. They set a "sector perform" rating and a $52.00 price target on the stock.March 14, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by Erste Asset Management GmbHErste Asset Management GmbH trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 352,781 shares of the medical researchMarch 14, 2025 | marketbeat.comAGF Management Ltd. Invests $2.67 Million in Exact Sciences Co. (NASDAQ:EXAS)AGF Management Ltd. purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 47,466 shares of the medical research company's stock, valued atMarch 14, 2025 | marketbeat.comRBC Capital Initiates Coverage of Exact Sciences (EXAS) with Sector Perform RecommendationMarch 13, 2025 | msn.comConnor Clark & Lunn Investment Management Ltd. Purchases 213,557 Shares of Exact Sciences Co. (NASDAQ:EXAS)Connor Clark & Lunn Investment Management Ltd. boosted its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 63.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 549,262 shares of the medical rMarch 13, 2025 | marketbeat.comExact Sciences initiated with a Sector Perform at RBC CapitalMarch 12, 2025 | markets.businessinsider.comExact Sciences Named 2025 Gallup Exceptional Workplace Award WinnerMarch 12, 2025 | finance.yahoo.comNew Data Highlight the Positive Impact of Exact Sciences' Oncotype DX® Test on Patient Care and Healthcare EfficiencyMarch 12, 2025 | businesswire.comCharles Schwab Investment Management Inc. Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS)Charles Schwab Investment Management Inc. increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,330,939 shares of the medical researchMarch 11, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Bought by AMF Tjanstepension ABAMF Tjanstepension AB raised its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 426.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 55,916 shares of the medical research company's stock afterMarch 9, 2025 | marketbeat.com8,405 Shares in Exact Sciences Co. (NASDAQ:EXAS) Acquired by Vestmark Advisory Solutions Inc.Vestmark Advisory Solutions Inc. purchased a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 8,405 shares of the medical research company's stock, valued atMarch 9, 2025 | marketbeat.comInceptionr LLC Makes New $406,000 Investment in Exact Sciences Co. (NASDAQ:EXAS)Inceptionr LLC acquired a new position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 7,230 shares of the medical research companyMarch 9, 2025 | marketbeat.comProficio Capital Partners LLC Makes New Investment in Exact Sciences Co. (NASDAQ:EXAS)Proficio Capital Partners LLC purchased a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm purchased 28,545 shares of the medical research company's stock, valued at approximately $1,604,000. A numbMarch 7, 2025 | marketbeat.comFisher Asset Management LLC Boosts Stake in Exact Sciences Co. (NASDAQ:EXAS)Fisher Asset Management LLC increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 43.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 176,637 shares of the medical research company's stockMarch 5, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Up 5.6% - Here's What HappenedExact Sciences (NASDAQ:EXAS) Trading 5.6% Higher - Should You Buy?March 4, 2025 | marketbeat.comExact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy NowMarch 4, 2025 | uk.finance.yahoo.comHere’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)March 4, 2025 | insidermonkey.comAtria Wealth Solutions Inc. Takes $316,000 Position in Exact Sciences Co. (NASDAQ:EXAS)Atria Wealth Solutions Inc. bought a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 5,621 shares of the medical research company's stock,March 1, 2025 | marketbeat.comGenerali Investments Towarzystwo Funduszy Inwestycyjnych Grows Position in Exact Sciences Co. (NASDAQ:EXAS)Generali Investments Towarzystwo Funduszy Inwestycyjnych increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 33.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,000 sharFebruary 28, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Price Target Cut to $70.00 by Analysts at Piper SandlerPiper Sandler dropped their price target on Exact Sciences from $75.00 to $70.00 and set an "overweight" rating on the stock in a research note on Wednesday.February 27, 2025 | marketbeat.comHeritage Investors Management Corp Sells 17,891 Shares of Exact Sciences Co. (NASDAQ:EXAS)Heritage Investors Management Corp lowered its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 19.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 76,395 shares of the medical research company's stFebruary 27, 2025 | marketbeat.comARK Investment Management LLC Has $4.50 Million Position in Exact Sciences Co. (NASDAQ:EXAS)ARK Investment Management LLC trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 64.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,059 shares of the meFebruary 27, 2025 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Given Consensus Rating of "Moderate Buy" by AnalystsShares of Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nineteen analysts that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and eighteen have issueFebruary 27, 2025 | marketbeat.comExact Sciences price target lowered to $70 from $75 at Piper SandlerFebruary 26, 2025 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Exact Sciences (EXAS)February 26, 2025 | markets.businessinsider.comIFP Advisors Inc Buys 39,067 Shares of Exact Sciences Co. (NASDAQ:EXAS)IFP Advisors Inc increased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 12,363.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,383 shares of the medical research company's stock afteFebruary 26, 2025 | marketbeat.comBTIG Sticks to Its Buy Rating for Exact Sciences (EXAS)February 25, 2025 | markets.businessinsider.comIeq Capital LLC Grows Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)Ieq Capital LLC grew its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 465.8% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 26,993 shares of the medical research company's stock after buyinFebruary 25, 2025 | marketbeat.comNew York State Common Retirement Fund Reduces Stock Holdings in Exact Sciences Co. (NASDAQ:EXAS)New York State Common Retirement Fund cut its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 29.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 210,162 shares of the medical research cFebruary 25, 2025 | marketbeat.comExact Sciences (NASDAQ:EXAS) Trading Up 4.8% After Analyst UpgradeExact Sciences (NASDAQ:EXAS) Shares Up 4.8% on Analyst UpgradeFebruary 24, 2025 | marketbeat.com2 Stocks Down 59% and 34% to Buy and HoldFebruary 24, 2025 | fool.comExact Sciences (NASDAQ:EXAS) Stock Price Expected to Rise, Scotiabank Analyst SaysScotiabank boosted their price objective on shares of Exact Sciences from $70.00 to $73.00 and gave the company a "sector outperform" rating in a research report on Monday.February 24, 2025 | marketbeat.comSkylands Capital LLC Has $663,000 Stake in Exact Sciences Co. (NASDAQ:EXAS)Skylands Capital LLC lifted its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2,850.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,800 shares of the medical researcFebruary 24, 2025 | marketbeat.comExact Sciences to Participate in March Investor ConferencesFebruary 24, 2025 | businesswire.com Remove Ads Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼1.370.63▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼810▲EXAS Articles Average Week Remove Ads Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News United Therapeutics News BioMarin Pharmaceutical News Incyte News Neurocrine Biosciences News Exelixis News Repligen News Halozyme Therapeutics News Madrigal Pharmaceuticals News Alkermes News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXAS Stock Free EXAS Stock Alerts